← All reports

Ireland's government is under pressure to fund the diabetes and weight-loss drug Mounjaro due to its high monthly cost for patients.

HealthcarePoliticsApr 22, 2026score 0.172 posts · 0 replies across 1 instances
The thread discusses Ireland's pressure to fund the diabetes and weight-loss drug Mounjaro, as patients face high monthly costs. It highlights a gap in public coverage and ongoing confidential negotiations. The issue centers on healthcare affordability and government responsibility.

Claims

Ireland's government is under pressure to fund the diabetes and weight-loss drug Mounjaro due to its high monthly cost for patients.
Parent: HealthcareEntity: MounjaroImpact: negativeDate: Apr 22, 2026Target: Ireland's government funding of Mounjaro

Source posts

@[email protected]
Ireland faces pressure to fund Mounjaro as patients bear €600-a-month cost [Advocacy Lab] https://www.euractiv.com/news/ireland-faces-pressure-to-fund-mounjaro-as-patients-bear-e600-a-month-cost/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv_agri%40eupolicy.social
0 boosts · 0 favs · 0 replies · Apr 22, 2026
@[email protected]
Ireland faces pressure to fund Mounjaro as patients bear €600-a-month cost [Advocacy Lab]: Senate debate highlights gap in public coverage for diabetes and weight-loss drug, confidential commercial negotiations are ongoing https://www.euractiv.com/news/ireland-faces-pressure-to-fund-mounjaro-as-patients-bear-e600-a-month-cost/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv_economy%40eupolicy.social
0 boosts · 0 favs · 0 replies · Apr 22, 2026